No Detail Found!

Frequency of New Hepatocellular Carcinoma in Patients Suffering from Hepatitis C Virus Infection Related Cirrhosis Exposed to Direct Acting Antiviral-based Therapy

Author(s)
IBTESAAM AMJAD Department of Medicine, Ameer ud Din Medical College, PGMI, Lahore General Hospital, Lahore, Pakistan
JUNAID MUSHTAQ Department of Medicine, Ameer ud Din Medical College, PGMI, Lahore General Hospital, Lahore, Pakistan
KANZA ALTAF Department of Radiology, Lahore General Hospital, Lahore, Pakistan
AHMED ZAKA SUBHANI Department of Medicine, Ameer ud Din Medical College, PGMI, Lahore General Hospital, Lahore, Pakistan
ISRAR-UL-HAQUE TOOR Department of Medicine, Ameer Ud Din Medical College, PGMI, Lahore General Hospital, Pakistan
GHIAS-UN-NABI TAYYAB Medicine Department, Ameer Ud Din Medical College, PGMI, Lahore General Hospital, Pakistan
Abstract
To find the frequency of hepatocellular carcinoma in patients with hepatitis C virus infection patients on dual antiviral therapy. Design of the study: Cross sectional study Settings: Department of Medicine/Division of Gastroenterology, Lahore General Hospital, Lahore. Duration: 6 months Sample Size: Sample size of 220 cases was calculated with 95% confidence level and 3.5% margin of error by taking percentage of HCC i.e. 7% in HCV patients on direct acting antiviral-based therapy. Data was analyzed with IBM-SPSS version 21. Results: In our study the mean age was 37.75±12.08 years. The mean value of duration of HCV therapy of the patients was 8.59±4.023 months. In this study the HCC was noted in 12(5.45%) patients. Conclusion: The frequency of HCC in patients with HCV infection patients on direct acting antiviral-based therapy is 5.45%.
Publication Details
Page(s) 1047-1049
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 03, Year: 2022

Request the full text from PASTIC

Keywords
Hepatitis C virus, hepatocellular carcinoma, Antiviral therapy
References
Mohd Hanafiah K,Groeger J,Flaxman AD,Wiersma ST .2013 .Global epidemiology of hepatitis C virus infection: New estimates of agespecific antibody to HCV seroprevalence. Hepatology, 57(4) : 1333-42.
Ott J,Stevens G,Groeger J,Wiersma S. .2012 .Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine, 30(12) : 2212-9.
Lavanchy D. .2011 .Evolving epidemiology of hepatitis C virus. Clinical Microbiology and Infection, 17(2) : 107-15.
van de Laar TJ,Matthews GV,Prins M,Danta M. .2010 .Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection. Aids, 24(12) : 1799-812.
Singal AK,Singh A,Jaganmohan S,Guturu P,Mummadi R,Kuo YF .2010 .Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis. Clinical Gastroenterology and Hepatology, 8(2) : 192-9.
Westbrook RH,Dusheiko G .2014 .Natural history of hepatitis C. Journal of hepatology, 61(1) : S58-S68.
Rindali L,Di Francia R,Coppola N,Guerrera B,Imparato M,Monari C .2016 .Hepatocellular carcinoma in HCV cirrhosis after viral clearance with direct acting antiviral therapy: preliminary evidence and possible meanings. World Canc Res J, 3(3) : e748.
Conti F,Buonfiglioli F,Scuteri A,Crespi C,Bolondi L,Caraceni P .2016 .Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. Journal of hepatology, 65(4) : 727-33.
Gramenzi A,Andreone P,Fiorino S,Camma C,Giunta M,Magalotti D .2001 .Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis. Gut, 48(6) : 843-8.
Yu M,Lin S-M W-L,Dai C-Y,Wang J-H,Lu S-N J-H .2006 .A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan. Antiviral therapy, 11(8) : 985.
Blonski W,Reddy KR .2008 .Hepatitis C virus infection and hepatocellular carcinoma. Clinics in liver disease, 12(3) : 661-74.
Liu CJ .2014 .Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues. Journal of gastroenterology and hepatology, 29(1) : 26-30.
Huang C-F M-L,Huang C-I,Lin Y-J,Tsai P-C Lin Z-Y .2017 .Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance. Oncotarget, 8(27) : 43925.
Hoshida Y,Fuchs BC,Bardeesy N,Baumert TF,Chung RT .2014 .Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma. Journal of hepatology, 61(1) : S79-S90.
Huang ,Jen C-L,Yang H-I,Lee M-H,Su J,Lu S-N .2011 .Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. Journal of Clinical Oncology, 29(27) : 3643-50.
0

Citations

0

Downloads

65

Views